Baker Tilly Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $854K | Sell |
4,602
-169
| -4% | -$31.4K | 0.31% | 73 |
|
|
2025
Q1 | $1,000K | Buy |
4,771
+881
| +23% | +$185K | 0.39% | 62 |
|
|
2024
Q4 | $691K | Buy |
3,890
+94
| +2% | +$16.7K | 0.27% | 87 |
|
|
2024
Q3 | $750K | Sell |
3,796
-1,256
| -25% | -$248K | 0.33% | 75 |
|
|
2024
Q2 | $867K | Sell |
5,052
-6,361
| -56% | -$1.09M | 0.35% | 66 |
|
|
2024
Q1 | $2.08M | Sell |
11,413
-1,945
| -15% | -$354K | 0.38% | 63 |
|
|
2023
Q4 | $2.07M | Sell |
13,358
-701
| -5% | -$109K | 0.34% | 65 |
|
|
2023
Q3 | $2.1M | Sell |
14,059
-2,923
| -17% | -$436K | 0.35% | 65 |
|
|
2023
Q2 | $2.29M | Sell |
16,982
-629
| -4% | -$84.7K | 0.24% | 90 |
|
|
2023
Q1 | $2.81M | Buy |
17,611
+728
| +4% | +$116K | 0.32% | 70 |
|
|
2022
Q4 | $2.73M | Buy |
16,883
+2,405
| +17% | +$389K | 0.34% | 73 |
|
|
2022
Q3 | $1.94M | Sell |
14,478
-2,225
| -13% | -$299K | 0.26% | 84 |
|
|
2022
Q2 | $2.56M | Sell |
16,703
-319
| -2% | -$48.9K | 0.34% | 69 |
|
|
2022
Q1 | $2.76M | Sell |
17,022
-1,464
| -8% | -$237K | 0.31% | 70 |
|
|
2021
Q4 | $2.5M | Sell |
18,486
-413
| -2% | -$55.9K | 0.27% | 74 |
|
|
2021
Q3 | $2.04M | Buy |
18,899
+1,012
| +6% | +$109K | 0.27% | 74 |
|
|
2021
Q2 | $2.02M | Buy |
17,887
+629
| +4% | +$70.9K | 0.33% | 70 |
|
|
2021
Q1 | $1.87M | Buy |
17,258
+3,341
| +24% | +$362K | 0.38% | 63 |
|
|
2020
Q4 | $1.49M | Buy |
+13,917
| New | +$1.49M | 0.46% | 50 |
|